Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
about
Nonalcoholic fatty liver diseaseTreatment of non-alcoholic fatty liver diseaseNAFLD and Chronic Kidney DiseaseStrategies to rescue steatotic livers before transplantation in clinical and experimental studiesNon-alcoholic fatty liver disease: need for a balanced nutritional sourceCeramide-mediated insulin resistance and impairment of cognitive-motor functionsNoninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.Pathogenesis of non-alcoholic fatty liver disease.Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline.The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitisTreatment options for nonalcoholic Fatty liver diseaseManagement of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesPathogenesis and therapeutic approaches for non-alcoholic fatty liver diseaseTreatment of non-alcoholic fatty liver disease.The metabolic syndrome and nonalcoholic fatty liver disease in childrenAdipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literatureImpact of pentoxifylline and vitamin e on ribavirin-induced haemolytic anaemia in chronic hepatitis C patients: an egyptian surveyPentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.Non-alcoholic fatty liver disease: The diagnosis and management.Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study.Mechanisms of ceramide-mediated neurodegeneration.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedRecent advances in the treatment of non-alcoholic fatty liver disease.Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.Ageing and metabolism: drug discovery opportunities.Treatment strategies in nonalcoholic fatty liver disease.Advances in the treatment of nonalcoholic fatty liver disease.Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes.Focus on therapeutic strategies of nonalcoholic Fatty liver diseaseHow should we manage patients with non-alcoholic fatty liver disease in 2007?Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).Nonalcoholic fatty liver disease: from clinical recognition to treatment.KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease: a potential consequence of tumor necrosis factor-inhibitor therapy.
P2860
Q24555779-8F66C664-8B89-4881-BEB7-18A1F78C713AQ24655572-AF136FD3-BEEF-4671-A84A-27F658BA9E7BQ26752759-E5EC1FFC-4106-4805-9979-1934FB6A4C8AQ27003912-360B86AF-4D12-4890-841B-E3344ADDC9F5Q28248994-821E27EA-B84F-42D2-B575-085A2E50B4ECQ30478907-68796194-CA1D-4FF6-928B-4A5C9EC83A64Q30479092-F0DA154A-4E0C-4381-9B08-7FD0BB652DDAQ33606303-474B889A-EFF6-41B3-A578-1491E0776304Q33723738-775ECB30-FB6B-4723-9C0B-C9A451A1F0AAQ33864337-44D303A7-69CD-4244-AD70-F7B911C04304Q33867088-99127FF8-06A5-4BE6-9FD8-4D579A6B1129Q33944689-5D6F23EF-C81C-4FF4-A4E6-C11E2C75C829Q34156317-9FD423BF-8CDF-4593-BDDC-4D1AFAB61A29Q34168532-FAF6D045-4F15-4A9A-BEA2-1ECD8FF62082Q34256132-48136F09-D4EB-4BDD-B608-DFEE4776F4B3Q34288447-95E6FB12-0721-48F0-93CB-E35ED60B5A03Q34449857-F96C7172-D973-4728-BA28-0A1923500AD4Q34592654-88223FD7-AF9B-4079-9271-6255B4B22C4EQ34778237-FA5C01C4-815C-459E-AC50-39A110912652Q34779049-2036D2E1-0D05-4B92-8EAD-B2F26FA78B8AQ35109416-CD8C6C13-B2C8-47D1-91CA-3CBF440C4222Q35207742-B0345396-13D6-49BC-BADE-2DF15DE5719BQ35490295-FF8E2B22-D2A0-4639-920A-99BAE96A9964Q35543956-FC85381D-D138-4C63-B5FB-E80310AB4CC5Q35986524-9B5D4A15-8D7B-4968-AE80-942FDB2E5204Q35997878-25799555-BDA7-4C4A-A08E-4C70D4D98EB1Q35997884-D4A15114-B097-4AF6-A251-718722D0566FQ36040859-F43BD3A3-BA8A-48B6-A088-41C0CE41B5AFQ36148926-30F4EE8B-37E6-41DF-9CF7-F07A8E8C5349Q36174012-100C287A-4D80-43EF-8639-08BC898E79FAQ36304115-189B5D7D-1D38-43B9-8458-34CF3EE5E343Q36329908-F5E2FA04-6E5F-4293-8DC0-0B2809D00F22Q36404495-A83ED244-94E5-417E-BC36-F4546015C314Q36413703-2557CAA2-C833-4353-89A3-5958A02CF335Q36848280-11FB7292-3AF9-4159-A70B-B9D6826A776BQ37149405-F4715157-FB84-4B89-A8F7-8C14EEAB86F9Q37278117-A0979323-48BE-4CF5-85C5-CC172665AC8EQ37345907-A8A2B9B1-E7F0-4901-B375-5AC55DCE9E4DQ37488800-3D8323AF-2DF1-4AAC-8116-84A02DC0AB58Q37505690-12F93C55-87C2-4500-B433-AA45D0B91E58
P2860
Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Beneficial effects of tumor ne ...... nonalcoholic steatohepatitis.
@en
Beneficial effects of tumor ne ...... nonalcoholic steatohepatitis.
@nl
type
label
Beneficial effects of tumor ne ...... nonalcoholic steatohepatitis.
@en
Beneficial effects of tumor ne ...... nonalcoholic steatohepatitis.
@nl
prefLabel
Beneficial effects of tumor ne ...... nonalcoholic steatohepatitis.
@en
Beneficial effects of tumor ne ...... nonalcoholic steatohepatitis.
@nl
P2093
P2860
P1476
Beneficial effects of tumor ne ...... nonalcoholic steatohepatitis.
@en
P2093
Barjesh C Sharma
Puja Sakhuja
Ranjeet Chauhan
Sanjay Garg
Sanjay K Satapathy
Shiv K Sarin
Veena Malhotra
P2860
P304
P356
10.1111/J.1572-0241.2004.40220.X
P407
P577
2004-10-01T00:00:00Z